HappeningToo topic
Empagliflozin reports
Browse community reports connected to Empagliflozin. These reports can show that other people are describing similar experiences, but they do not prove that Empagliflozin caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
36 problems
Abdominal Discomfort while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and abdominal discomfort appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Distension while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and abdominal distension appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and abdominal pain upper appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and abdominal pain appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Anxiety while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and anxiety appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Back Pain while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and back pain appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and constipation appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Cough while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and cough appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Decreased Appetite while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and decreased appetite appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dehydration while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and dehydration appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and diarrhea appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and dizziness appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and dyspepsia appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Excessive sweating while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and excessive sweating appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and fatigue appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Feeling Abnormal while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and feeling abnormal appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and headache appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hypotension while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and hypotension appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and insomnia appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Itching while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and itching appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and malaise appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and muscle spasms appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Myalgia while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and myalgia appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and nausea appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and pain appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Palpitations while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and palpitations appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Peripheral swelling while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and peripheral swelling appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and rash appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and shortness of breath appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Sleepiness while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and sleepiness appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tremor while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and tremor appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vision Blurred while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and vision blurred appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and vomiting appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and weakness appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Decreased while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and weight decreased appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Empagliflozin
FDA FAERS contains adverse-event reports in which Empagliflozin and weight increased appear together. This does not establish that Empagliflozin caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →